Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
9 June 2016
Header
Header image
News

News

EFPIA launches Blog Series to Back UN SDGs
09 June 2016

The United Nations’ sustainable development goals provide the reference point for global efforts to improve the living conditions of those left behind by economic growth. [...] Read more

News

EBE and EFPIA Applaud EMA Initiative to Improve Pathway for Advanced Therapy Medicinal Products (ATMPs)
08 June 2016

EBE and EFPIA both welcome sincerely the initiative taken by the European Medicines Agency to identify concrete solutions to foster the development of advanced therapy [...] Read more

News

“A Healthier Future: From Innovation to Outcomes”: Andriukaitis and Oettinger lead the debate at the EFPIA Annual Conference 2016
09 June 2016

This year’s EFPIA Annual Conference will focus on the challenges faced by European health systems, the role of innovation in meeting these challenges, and how [...] Read more

From our blog

From our blog

Antibiotic-Resistant Infections: Life without Fire Extinguishers (Guest blog)
09 June 2016 by John Rex

In the pre-antibiotic era, a simple bacterial infection could kill a previously healthy adult in just a few days. Mortality rates could be astonishing and indeed at least 30% of all deaths in the US in 1900 were due to infections, according to Centers for Disease Control and Prevention.

Read more

From our blog

Innovation is the life-blood of our industry: how do we keep it pumping? (Guest blog)
09 June 2016 by Luc Debruyne

Partnership is recognised increasingly as a key success factor in innovation, particularly in our industry. The best partnerships start with good intent and enthusiasm. Even then, making them work is no easy feat.

Read more

From our blog

A European-African alliance working in collaboration with pharmaceutical companies to strengthen clinical capacity to fight poverty-related diseases (Guest blog)
09 June 2016 by Ana Lúcia Cardoso & Michelle Nderu

Ensuring that clinical research in Africa is conducted in accordance with the highest international standards and that highly qualified local researchers contribute to this process is the cornerstone of the partnership between the European & Developing Countries Clinical Trials Partnership (EDCTP) and the European Federation of Pharmaceutical Industries and Associations (EFPIA).

Read more

From our blog

Healthcare professionals support increased transparency – but will they disclose? (Guest blog)
09 June 2016 by Karen Borrer

According to a recent poll, the vast majority of UK doctors, nurses, pharmacists and hospital specialists agree that payments from pharmaceutical companies to individual healthcare professionals (HCPs) should be transparent.

Read more

Videos

Video

From Innovation to Outcomes: Interview with Joseph Jimenez, CEO Novartis & EFPIA President

Interview with Joseph Jimenez about the upcoming 2016 EFPIA Annual Conference, entitled: "A Healthier Future: From innovation to outcomes".

View video

Events calendar

Events Calendar

EFPIA Annual Conference 2016
On 15/06/2016 (Radisson Hotel, Brussels)

This year's EFPIA Annual Conference will take place on 15 June 2016, at the Radisson Hotel in Brussels. The event will examine the challenges faced by healthcare systems in Europe, the exciting science that will play a key role in meeting these challenges and the long-term sustainability of healthcare delivery. An interactive exhibition will be set up to provide attendees with further insight into EFPIA’s current initiatives, which aim at facilitating a pan-European dialogue on the importance of shifting towards a model of outcomes-driven healthcare.
 
The final programme can be accessed here
 
Read more

Documents

From our blog

Report on a meeting between EFPIA and DG SANTE on 10 May 2016
09 June 2016 (Reports & Studies)

The purpose of the meeting was to discuss the EFPIA - EUnetHTA event `Joint REA at time of launch involving Member States’ HTA authorities and [...] Read more

What we are reading

What we are reading

Factsheet on Antimicrobial resistance
09 June 2016 (FAO - WHO - OIE)

Antimicrobial resistance is a serious public health threat. Bacteria, viruses, fungi, and parasites are all microbes. They cause diseases like pneumonia, HIV, candidemia (the most common bloodstream infection in hospital patients), and malaria, as well as severe diseases in animals. All types of microbes can develop resistance to the medicines that have been developed to kill them. Common infections are becoming resistant to all available medicines. 

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail